A Bill & Melinda Gates Foundation strategic investment to tackle bacterial vaginosis and improve maternal and neonatal health outcomes worldwide.
Industry
Sponsored by
Biofarma Group has launched an innovative project in collaboration with the Department of Surgery, Endocrinology and Gastroenterology of the University of Naples ‘Federico II’, the Centro Sperimentale del Latte (CSL)…
The results also indicate that the hospital environment influences the gut bacteria of preterm infants, highligting the importance of managing antibiotics and medications to support a healthy gut development.
A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).
Three-year collaboration to pioneer new insights in microbial sciences and health applications.
The interview with Björn O. Schröder from Umeå University explores groundbreaking research on the gut mucus layer, which shields intestinal tissues from bacterial invasion and inflammation.
New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.
The findings improve our understanding of the genetic complexity of the human gut microbiota and its implications for health.
The findings highlight the complex interactions between some dietary compounds and the gut microbiota, suggesting that microbial variations can impact health in different ways.
October 2024 saw notable activity in mergers, acquisitions, and strategic investments within the biotech and life sciences industries.
